IPCA LABORATORIES
Back to Cashflow Statement
|
IPCA LABORATORIES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-754 Cr | ₹-283 Cr | ₹-553 Cr | ₹507 Cr | ₹427 Cr |
What is the latest Cash Flow from Financing Activities ratio of IPCA LABORATORIES ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹-754 Cr |
| Mar2025 | ₹-283 Cr |
| Mar2024 | ₹-553 Cr |
| Mar2023 | ₹507 Cr |
| Mar2022 | ₹427 Cr |
How is Cash Flow from Financing Activities of IPCA LABORATORIES Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-754 Cr | Negative | |
| Mar2025 | ₹-283 Cr | Negative | |
| Mar2024 | ₹-553 Cr | Negative | |
| Mar2023 | ₹507 Cr | 18.85 | |
| Mar2022 | ₹427 Cr | - | |
Compare Cash Flow from Financing Activities of peers of IPCA LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| IPCA LABORATORIES | ₹49,268.5 Cr | -0.3% | 0.7% | 48.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹459,497.0 Cr | 8.1% | 9.3% | 9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹294,146.0 Cr | 10.5% | 18% | 51.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,474.0 Cr | 2.9% | 2.1% | 30.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,349.0 Cr | -0.1% | 16% | 14.6% | Stock Analytics | |
| CIPLA | ₹113,989.0 Cr | 1.4% | 8.1% | -6.8% | Stock Analytics | |
IPCA LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| IPCA LABORATORIES | -0.3% |
0.7% |
48.3% |
| SENSEX | 7% |
11.5% |
-3.5% |
You may also like the below Video Courses